4Goasguen JE, Bennett JM. Classification and morphologic features of the myelodysplastic syndromes. Semin Oncol, 1992,19 : 4-13.
5Ganser A, Hoelzer D. Clinical course of myelodysplastic syndromes. Hematol Oncol Clin North Am, 1992, 6: 6074517.
6Brunning RD, Bennett JM, Flandrin G, et al. Myelodysplastic syndromes//Jaffe ES, Harris NL, Stein H, et al. World Health Organization classification of tumours. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001:62-73.
7Valent P, Horny HP, Bennett JM, et al. Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference. Leuk Res , 2007, 31:727-736.
8Germing U, Strupp C, Kuendgen A , et al. Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes. Haematologica, 2006, 91: 1596-1604.
9Schiffer CA. World Health Organization and international prognostic scoring system: the limitations of current classification systems in assessing prognosis and determining appropriate therapy in myelodysplastic syndromes. Semin Hematol, 2008, 45:3-7.
10Verburgh E, Achten R, Louw VJ, et al. A new disease categorization of low-grade myelodysplastic syndromes based on the expression of cytopenia and dysplasia in one versus more than one lineage improves on the WHO classification. Leukemia, 2007,21 : 668- 677.
